Results 111 to 120 of about 50,528 (188)

Tucidinostat plus pediatric-inspired chemotherapy for newly diagnosed adult ETP-ALL/LBL: a single-arm, phase 2 trial

open access: yesJournal of Hematology & Oncology
Early T-cell precursor lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) is a distinct subtype of T-ALL/LBL, characterized by a poor response to initial chemotherapy, a high relapse rate, and an inferior outcome.
Jieping Lin   +14 more
doaj   +1 more source

EXECUTIVE CONTROL ABILITIES AND SELF-REGULATION IN SURVIVORS OF CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA [PDF]

open access: yesKhyber Medical University Journal, 2018
OBJECTIVE: To examine executive control and self-regulation abilities in survivors of childhood acute lymphocytic leukemia (ALL). METHODS: In this cross-sectional study, thirty-five survivors of childhood ALL from Sahukat Khanum Memorial Cancer ...
Amara Gul, Sadia Zafar
doaj  

Global Stability of McKeithan's Kinetic Proofreading Model for T-Cell Receptor Signal Transduction [PDF]

open access: yesarXiv, 1999
This note presents a self-contained and streamlined exposition of chemical-network results due to Feinberg, Horn, and Jackson. As an application, it shows the global asymptotic stability to equilibria of McKeithan's kinetic proofreading model for T-cell receptor signal transduction.
arxiv  

Automated Immunophenotyping Assessment for Diagnosing Childhood Acute Leukemia using Set-Transformers [PDF]

open access: yesarXiv
Acute Leukemia is the most common hematologic malignancy in children and adolescents. A key methodology in the diagnostic evaluation of this malignancy is immunophenotyping based on Multiparameter Flow Cytometry (FCM). However, this approach is manual, and thus time-consuming and subjective. To alleviate this situation, we propose in this paper the FCM-
arxiv  

Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma

open access: yesOncoTarget, 2016
T cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) is a precursor T cell leukemia/lymphoma that represents approximately 15% of all childhood and 25% of adult acute lymphoblastic leukemia.
D. Habiel   +7 more
semanticscholar   +1 more source

gghic: A Versatile R Package for Exploring and Visualizing 3D Genome Organization [PDF]

open access: yesarXiv
Motivation: The three-dimensional (3D) organization of the genome plays a critical role in regulating gene expression and maintaining cellular homeostasis. Disruptions in this spatial organization can result in abnormal chromatin interactions, contributing to the development of various diseases including cancer.
arxiv  

Control of human immune response function by T-cell population fluctuation and relaxation dynamics [PDF]

open access: yesarXiv, 2015
Clinical studies have indicated that in malignant surveillances fluctuations in the population of certain effector T-cell repertoire become suppressed. Motivated by such observations and in an attempt to quantify adaptive human response to pathogens, we define an immune response function (IMRF) in terms of mean square fluctuations of T-cell ...
arxiv  

Abstracts

open access: yesMolecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Transfer Learning for T-Cell Response Prediction [PDF]

open access: yesarXiv
We study the prediction of T-cell response for specific given peptides, which could, among other applications, be a crucial step towards the development of personalized cancer vaccines. It is a challenging task due to limited, heterogeneous training data featuring a multi-domain structure; such data entail the danger of shortcut learning, where models ...
arxiv  

Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials

open access: yesMolecular Therapy: Methods & Clinical Development, 2020
Tisagenlecleucel is a CD19-specific chimeric antigen receptor (CAR)-T cell therapy approved for patients aged ≤25 years with relapsed or refractory B cell precursor acute lymphoblastic leukemia (B-ALL) and adults with relapsed or refractory diffuse large
Seshu Tyagarajan   +2 more
doaj  

Home - About - Disclaimer - Privacy